Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/130583COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures |
Autor: | Curiel-Olmo, Soraya; Vidal, Rebeca CSIC ORCID; Varela, Ignacio CSIC ORCID; Moreno, Thaidy CSIC; Madureira, Rebeca CSIC; Valdizán, Elsa M. CSIC ORCID; Piris, Miguel A.; Vaqué, José P. CSIC ORCID | Palabras clave: | BRAF Targeted therapy Melanoma MAPK Somatic mutations |
Fecha de publicación: | 2015 | Editor: | Impact Journals | Citación: | Oncotarget 6(28): 25452-25465 (2015) | Resumen: | Targeted treatment of advanced melanoma could benefit from the precise molecular characterization of melanoma samples. Using a melanoma-specific selection of 217 genes, we performed targeted deep sequencing of a series of biopsies, from advanced melanoma cases, with a Breslow index of =4 mm, and/or with a loco-regional infiltration in lymph nodes or presenting distant metastasis, as well of a collection of human cell lines. This approach detected 3-4 mutations per case, constituting unique mutational signatures associated with specific inhibitor sensitivity. Functionally, case-specific combinations of inhibitors that simultaneously targeted MAPK-dependent and MAPK-independent mechanisms were most effective at inhibiting melanoma growth, against each specific mutational background. These observations were challenged by characterizing a freshly resected biopsy from a metastatic lesion located in the skin and soft tissue and by testing its associated therapy ex vivo and in vivo using melanocytes and patient-derived xenografted mice, respectively. The results show that upon mutational characterization of advanced melanoma patients, specific mutational profiles can be used for selecting drugs that simultaneously target several deregulated genes/pathways involved in tumor generation or progression. | Descripción: | This is an open-access article distributed under the terms of the Creative Commons Attribution License.-- et al. | Versión del editor: | http://dx.doi.org/10.18632/oncotarget.4545 | URI: | http://hdl.handle.net/10261/130583 | DOI: | 10.18632/oncotarget.4545 | Identificadores: | doi: 10.18632/oncotarget.4545 e-issn: 1949-2553 |
| Aparece en las colecciones: | (IBBTEC) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Individualized strategies.pdf | 8,57 MB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
3
checked on 06-may-2024
SCOPUSTM
Citations
3
checked on 01-may-2024
WEB OF SCIENCETM
Citations
3
checked on 26-feb-2024
Page view(s)
257
checked on 06-may-2024
Download(s)
283
checked on 06-may-2024
